Funding for this research was provided by:
National Institutes of Health (AG042178, AG047812, NS105473, AG060767, AG069333, AG066347 and AG060836)
Article History
Received: 17 December 2020
Accepted: 15 March 2021
First Online: 26 March 2021
Declarations
:
: Presented research is in compliance with ethical standards.
: Not applicable.
: All authors agreed to publish the contents.
: A patent is pending for the discovery of molecule, DDQ, and we have a minority financial interest with a small business company abSynapTex, LLC, based at Lubbock, TX, USA.